Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
292 studies found for:    "Glomerulonephritis"
Show Display Options
Rank Status Study
21 Unknown  ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT
Condition: Glomerulonephritis, IGA
Interventions: Drug: prednisone + Inhibace/Cozaar;   Drug: Inhibace/Cozaar
22 Completed Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
Condition: Glomerulonephritis, IGA
Intervention: Procedure: gene transcription and cytometry
23 Completed
Has Results
A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
Condition: Glomerulonephritis, Membranous
Intervention: Drug: belimumab
24 Recruiting Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: Rituximab;   Drug: Methylprednisolone;   Drug: Cyclophosphamide
25 Completed BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis
Conditions: Glomerulonephritis, Membranoproliferative;   Lupus Nephritis
Intervention: Drug: BG9588
26 Recruiting Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)
Condition: IgA Glomerulonephritis
Interventions: Drug: methylprednisolone;   Drug: Placebo
27 Recruiting Efficacy and Safety of Losartan in Children With Ig A Nephropathy
Condition: Glomerulonephritis, IGA
Intervention: Drug: Losartan
28 Withdrawn Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: Belimumab 10 mg;   Drug: Placebo
29 Recruiting Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: Mycophenolate mofetil, low dose steroid;   Drug: Cyclosporin, low dose steroid
30 Completed Mycophenolate Mofetil in Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: mycophenolate mofetil orally 1000 mg twice a day (BID);   Drug: prednisone 0,5 mg/kg orally on alternate days;   Drug: intravenous (i.v.) methylprednisolone 1000 mg, total 9
31 Completed Treatment of Patients With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Intervention: Drug: Cyclophosphamide and steroids
32 Completed Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
Conditions: Membranous Glomerulonephritis;   Lupus Membranous Nepropathy
Intervention: Drug: Sirolimus
33 Not yet recruiting A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN
Conditions: C3 Glomerulonephritis;   Dense Deposit Disease;   Membranoproliferative Glomerulonephritis, Type II;   C3 Glomerulopathy;   Immune Complex Mediated Membranoproliferative Glomerulonephritis
Intervention: Drug: ACH-0144471
34 Unknown  A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy
Conditions: Glomerulonephritis, IGA;   Hypertension
Intervention: Drug: aliskiren
35 Completed A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Conditions: Glomerulonephritis;   IGA Nephropathy
Interventions: Drug: Valsartan;   Drug: Probucol;   Drug: Placebo
36 Unknown  Calcitriol in the Treatment of Immunoglobulin A Nephropathy
Conditions: Glomerulonephritis;   Autoimmune Diseases
Intervention: Drug: Calcitriol
37 Active, not recruiting Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
Conditions: Glomerulonephritis;   IgAN
Interventions: Drug: ATG-F;   Drug: Simulect
38 Completed Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Conditions: Nephritis;   Systemic Lupus Erythematosus
Intervention: Drug: AMG 811
39 Recruiting ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Condition: SLE Glomerulonephritis Syndrome, WHO Class V
Intervention: Drug: Acthar gel
40 Completed Hospital Based Incidence of Group A Streptococcal Disease in Fiji
Condition: Streptococcus Group A

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.